pathology_id stringlengths 19 19 | country stringclasses 7
values | year int64 2.02k 2.03k | facility_type stringclasses 3
values | cancer_type stringclasses 10
values | icd_o_morphology_code stringclasses 9
values | morphology_description stringclasses 9
values | grade stringclasses 4
values | lymphovascular_invasion stringclasses 3
values | perineural_invasion stringclasses 3
values | margin_status stringclasses 4
values | ihc_er stringclasses 3
values | ihc_pr stringclasses 3
values | ihc_her2 stringclasses 4
values | ihc_ki67_index stringclasses 825
values | ihc_p53 stringclasses 3
values | molecular_subtype stringclasses 4
values | specimen_type stringclasses 4
values | diagnosis_confirmed stringclasses 3
values | turnaround_time_days int64 3 27 | scenario stringclasses 1
value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
PATH-ETH-2021-00201 | Ethiopia | 2,021 | National referral | Breast | 8140/3 | Adenocarcinoma | Moderately differentiated | Absent | Absent | Negative | Not done | Negative | Negative | 68.0 | Not done | Luminal B | Core needle biopsy | Yes | 23 | moderate_burden |
PATH-UGA-2019-00202 | Uganda | 2,019 | National referral | Ovary | 8140/3 | Adenocarcinoma | Poorly differentiated | Absent | Not documented | Negative | Positive | Negative | Negative | 58.3 | Positive | null | Resection | No - inconclusive | 6 | moderate_burden |
PATH-SOU-2024-00203 | South Africa | 2,024 | District | Ovary | 8260/3 | Papillary carcinoma | Moderately differentiated | Not documented | Absent | Negative | Negative | Negative | Negative | Not done | Negative | null | Core needle biopsy | Yes | 12 | moderate_burden |
PATH-NIG-2024-00204 | Nigeria | 2,024 | National referral | Breast | 8070/3 | Squamous cell carcinoma | Moderately differentiated | Absent | Not documented | Negative | Positive | Positive | Not done | 46.9 | Positive | Triple negative | Core needle biopsy | Yes | 19 | moderate_burden |
PATH-NIG-2025-00205 | Nigeria | 2,025 | District | Breast | 8260/3 | Papillary carcinoma | Poorly differentiated | Present | Absent | Negative | Positive | Not done | Negative | 34.2 | Positive | Luminal A | Excisional biopsy | Yes | 27 | moderate_burden |
PATH-SOU-2022-00206 | South Africa | 2,022 | Regional | Liver | 8310/3 | Clear cell carcinoma | Moderately differentiated | Present | Absent | Positive | Positive | Negative | Positive | 27.7 | Negative | null | Core needle biopsy | Yes | 21 | moderate_burden |
PATH-UGA-2021-00207 | Uganda | 2,021 | Regional | Bladder | 8140/3 | Adenocarcinoma | Poorly differentiated | Present | Not documented | Negative | Positive | Not done | Negative | 15.8 | Negative | null | Resection | Yes | 4 | moderate_burden |
PATH-SOU-2018-00208 | South Africa | 2,018 | Regional | Prostate | 8140/3 | Adenocarcinoma | Moderately differentiated | Not documented | Absent | Close | Positive | Negative | Positive | 15.7 | Positive | null | Excisional biopsy | No - inconclusive | 14 | moderate_burden |
PATH-GHA-2023-00209 | Ghana | 2,023 | National referral | Breast | 8140/3 | Adenocarcinoma | Well differentiated | Present | Not documented | Negative | Positive | Positive | Positive | 13.6 | Positive | Luminal A | Core needle biopsy | Yes | 15 | moderate_burden |
PATH-GHA-2019-00210 | Ghana | 2,019 | District | Bladder | 8140/3 | Adenocarcinoma | Moderately differentiated | Absent | Absent | Close | Negative | Positive | Negative | Not done | Negative | null | Core needle biopsy | Yes | 13 | moderate_burden |
PATH-ETH-2019-00211 | Ethiopia | 2,019 | District | Lung | 8720/3 | Melanoma | Moderately differentiated | Absent | Present | Close | Positive | Positive | Positive | Not done | Positive | null | Excisional biopsy | Yes | 25 | moderate_burden |
PATH-SOU-2024-00212 | South Africa | 2,024 | Regional | Prostate | 8140/3 | Adenocarcinoma | Moderately differentiated | Absent | Not documented | Negative | Negative | Positive | Negative | 8.4 | Negative | null | Resection | Yes | 4 | moderate_burden |
PATH-GHA-2020-00213 | Ghana | 2,020 | District | Lung | 8140/3 | Adenocarcinoma | Poorly differentiated | Absent | Absent | Negative | Negative | Negative | Equivocal | Not done | Negative | null | Fine needle aspirate | Yes | 10 | moderate_burden |
PATH-KEN-2019-00214 | Kenya | 2,019 | District | Cervix | 8260/3 | Papillary carcinoma | Poorly differentiated | Absent | Absent | Negative | Positive | Negative | Equivocal | 85.7 | Negative | null | Core needle biopsy | Yes | 19 | moderate_burden |
PATH-ETH-2018-00215 | Ethiopia | 2,018 | National referral | Stomach | 8070/3 | Squamous cell carcinoma | Poorly differentiated | Absent | Not documented | Close | Positive | Not done | Negative | 21.1 | Not done | null | Excisional biopsy | Yes | 13 | moderate_burden |
PATH-GHA-2025-00216 | Ghana | 2,025 | District | Thyroid | 8140/3 | Adenocarcinoma | Undifferentiated | Present | Present | Close | Positive | Positive | Not done | 25.7 | Positive | null | Excisional biopsy | Yes | 23 | moderate_burden |
PATH-TAN-2022-00217 | Tanzania | 2,022 | District | Colorectal | 8260/3 | Papillary carcinoma | Moderately differentiated | Absent | Not documented | Negative | Positive | Negative | Positive | 31.6 | Positive | null | Core needle biopsy | Yes | 21 | moderate_burden |
PATH-UGA-2022-00218 | Uganda | 2,022 | District | Colorectal | 8260/3 | Papillary carcinoma | Moderately differentiated | Present | Not documented | Negative | Positive | Negative | Negative | Not done | Positive | null | Excisional biopsy | Yes | 22 | moderate_burden |
PATH-TAN-2021-00219 | Tanzania | 2,021 | Regional | Stomach | 8500/3 | Ductal carcinoma | Poorly differentiated | Absent | Not documented | Not applicable | Positive | Positive | Negative | 78.5 | Negative | null | Core needle biopsy | Yes | 15 | moderate_burden |
PATH-ETH-2025-00220 | Ethiopia | 2,025 | Regional | Thyroid | 8070/3 | Squamous cell carcinoma | Poorly differentiated | Present | Absent | Negative | Positive | Negative | Not done | 74.2 | Positive | null | Core needle biopsy | Yes | 25 | moderate_burden |
PATH-GHA-2018-00221 | Ghana | 2,018 | Regional | Stomach | 8140/3 | Adenocarcinoma | Poorly differentiated | Present | Absent | Not applicable | Positive | Positive | Negative | Not done | Positive | null | Excisional biopsy | Yes | 21 | moderate_burden |
PATH-TAN-2020-00222 | Tanzania | 2,020 | National referral | Lung | 8310/3 | Clear cell carcinoma | Poorly differentiated | Absent | Absent | Negative | Negative | Negative | Positive | 32.4 | Negative | null | Core needle biopsy | Yes | 15 | moderate_burden |
PATH-ETH-2018-00223 | Ethiopia | 2,018 | District | Stomach | 8500/3 | Ductal carcinoma | Poorly differentiated | Present | Not documented | Negative | Positive | Negative | Positive | 87.3 | Negative | null | Core needle biopsy | Yes | 23 | moderate_burden |
PATH-TAN-2022-00224 | Tanzania | 2,022 | District | Ovary | 8260/3 | Papillary carcinoma | Undifferentiated | Present | Absent | Negative | Positive | Not done | Negative | Not done | Positive | null | Core needle biopsy | Yes | 6 | moderate_burden |
PATH-UGA-2020-00225 | Uganda | 2,020 | Regional | Ovary | 8140/3 | Adenocarcinoma | Poorly differentiated | Absent | Not documented | Negative | Positive | Negative | Positive | 29.1 | Positive | null | Core needle biopsy | Yes | 3 | moderate_burden |
PATH-KEN-2023-00226 | Kenya | 2,023 | Regional | Stomach | 8310/3 | Clear cell carcinoma | Moderately differentiated | Absent | Present | Negative | Positive | Positive | Negative | 89.6 | Negative | null | Core needle biopsy | Yes | 25 | moderate_burden |
PATH-SOU-2021-00227 | South Africa | 2,021 | District | Cervix | 8500/3 | Ductal carcinoma | Moderately differentiated | Absent | Absent | Positive | Positive | Positive | Negative | Not done | Positive | null | Excisional biopsy | Yes | 8 | moderate_burden |
PATH-UGA-2019-00228 | Uganda | 2,019 | Regional | Lung | 8310/3 | Clear cell carcinoma | Moderately differentiated | Present | Not documented | Close | Positive | Positive | Negative | 28.3 | Negative | null | Resection | No - inconclusive | 8 | moderate_burden |
PATH-UGA-2018-00229 | Uganda | 2,018 | District | Bladder | 8140/3 | Adenocarcinoma | Well differentiated | Absent | Not documented | Negative | Negative | Positive | Negative | Not done | Positive | null | Excisional biopsy | Yes | 16 | moderate_burden |
PATH-UGA-2020-00230 | Uganda | 2,020 | National referral | Thyroid | 8070/3 | Squamous cell carcinoma | Poorly differentiated | Absent | Not documented | Negative | Negative | Negative | Negative | 11.3 | Positive | null | Excisional biopsy | No - inconclusive | 11 | moderate_burden |
PATH-GHA-2025-00231 | Ghana | 2,025 | Regional | Thyroid | 8140/3 | Adenocarcinoma | Poorly differentiated | Present | Present | Negative | Positive | Negative | Negative | 60.9 | Negative | null | Resection | No - inconclusive | 9 | moderate_burden |
PATH-GHA-2020-00232 | Ghana | 2,020 | Regional | Cervix | 8310/3 | Clear cell carcinoma | Well differentiated | Absent | Present | Not applicable | Positive | Negative | Negative | Not done | Negative | null | Excisional biopsy | Yes | 15 | moderate_burden |
PATH-TAN-2019-00233 | Tanzania | 2,019 | Regional | Colorectal | 8500/3 | Ductal carcinoma | Well differentiated | Not documented | Present | Not applicable | Positive | Negative | Negative | 69.2 | Not done | null | Core needle biopsy | Yes | 18 | moderate_burden |
PATH-SOU-2024-00234 | South Africa | 2,024 | National referral | Cervix | 8140/3 | Adenocarcinoma | Poorly differentiated | Absent | Present | Close | Not done | Negative | Negative | 74.0 | Positive | null | Core needle biopsy | Yes | 20 | moderate_burden |
PATH-UGA-2019-00235 | Uganda | 2,019 | National referral | Liver | 8070/3 | Squamous cell carcinoma | Well differentiated | Present | Present | Negative | Positive | Negative | Negative | 68.8 | Positive | null | Core needle biopsy | No - suboptimal | 11 | moderate_burden |
PATH-UGA-2018-00236 | Uganda | 2,018 | National referral | Prostate | 8070/3 | Squamous cell carcinoma | Moderately differentiated | Absent | Absent | Negative | Negative | Negative | Negative | 81.9 | Negative | null | Core needle biopsy | Yes | 23 | moderate_burden |
PATH-UGA-2020-00237 | Uganda | 2,020 | District | Breast | 8500/3 | Ductal carcinoma | Well differentiated | Absent | Not documented | Positive | Positive | Negative | Negative | Not done | Positive | Luminal A | Resection | Yes | 26 | moderate_burden |
PATH-KEN-2018-00238 | Kenya | 2,018 | District | Cervix | 8070/3 | Squamous cell carcinoma | Moderately differentiated | Present | Not documented | Positive | Positive | Positive | Negative | 89.2 | Negative | null | Excisional biopsy | Yes | 23 | moderate_burden |
PATH-TAN-2022-00239 | Tanzania | 2,022 | National referral | Liver | 8430/3 | Mucoepidermoid carcinoma | Poorly differentiated | Absent | Absent | Negative | Negative | Not done | Negative | 76.0 | Negative | null | Core needle biopsy | Yes | 18 | moderate_burden |
PATH-NIG-2019-00240 | Nigeria | 2,019 | Regional | Cervix | 8140/3 | Adenocarcinoma | Well differentiated | Present | Absent | Negative | Negative | Positive | Negative | 48.0 | Positive | null | Core needle biopsy | No - inconclusive | 7 | moderate_burden |
PATH-ETH-2025-00241 | Ethiopia | 2,025 | District | Ovary | 8070/3 | Squamous cell carcinoma | Undifferentiated | Absent | Absent | Not applicable | Positive | Positive | Negative | 61.7 | Not done | null | Core needle biopsy | Yes | 24 | moderate_burden |
PATH-UGA-2020-00242 | Uganda | 2,020 | Regional | Ovary | 8500/3 | Ductal carcinoma | Poorly differentiated | Not documented | Not documented | Positive | Positive | Positive | Negative | 67.5 | Positive | null | Core needle biopsy | No - inconclusive | 24 | moderate_burden |
PATH-ETH-2021-00243 | Ethiopia | 2,021 | National referral | Breast | 8140/3 | Adenocarcinoma | Moderately differentiated | Absent | Absent | Negative | Negative | Positive | Negative | 36.7 | Negative | Luminal B | Core needle biopsy | Yes | 17 | moderate_burden |
PATH-KEN-2020-00244 | Kenya | 2,020 | National referral | Breast | 8500/3 | Ductal carcinoma | Moderately differentiated | Absent | Present | Close | Positive | Not done | Not done | 76.4 | Negative | Luminal B | Core needle biopsy | Yes | 4 | moderate_burden |
PATH-TAN-2022-00245 | Tanzania | 2,022 | District | Liver | 8500/3 | Ductal carcinoma | Well differentiated | Absent | Absent | Negative | Positive | Negative | Positive | Not done | Negative | null | Resection | No - inconclusive | 9 | moderate_burden |
PATH-GHA-2021-00246 | Ghana | 2,021 | District | Cervix | 8720/3 | Melanoma | Poorly differentiated | Absent | Not documented | Close | Positive | Negative | Negative | 22.0 | Not done | null | Resection | Yes | 16 | moderate_burden |
PATH-GHA-2018-00247 | Ghana | 2,018 | National referral | Ovary | 8260/3 | Papillary carcinoma | Poorly differentiated | Not documented | Not documented | Close | Negative | Positive | Negative | 17.5 | Not done | null | Resection | Yes | 8 | moderate_burden |
PATH-GHA-2018-00248 | Ghana | 2,018 | National referral | Liver | 8500/3 | Ductal carcinoma | Poorly differentiated | Absent | Not documented | Negative | Positive | Negative | Negative | 13.5 | Not done | null | Resection | Yes | 11 | moderate_burden |
PATH-NIG-2019-00249 | Nigeria | 2,019 | National referral | Bladder | 8140/3 | Adenocarcinoma | Moderately differentiated | Absent | Present | Close | Not done | Not done | Negative | 78.0 | Not done | null | Excisional biopsy | Yes | 11 | moderate_burden |
PATH-KEN-2018-00250 | Kenya | 2,018 | Regional | Liver | 8500/3 | Ductal carcinoma | Undifferentiated | Not documented | Absent | Negative | Negative | Positive | Negative | 9.1 | Positive | null | Core needle biopsy | Yes | 10 | moderate_burden |
PATH-UGA-2019-00251 | Uganda | 2,019 | National referral | Colorectal | 8070/3 | Squamous cell carcinoma | Poorly differentiated | Present | Absent | Negative | Positive | Positive | Negative | 54.6 | Negative | null | Core needle biopsy | Yes | 18 | moderate_burden |
PATH-KEN-2019-00252 | Kenya | 2,019 | District | Breast | 8510/3 | Medullary carcinoma | Undifferentiated | Absent | Absent | Close | Positive | Negative | Not done | 38.3 | Negative | Triple negative | Core needle biopsy | Yes | 8 | moderate_burden |
PATH-NIG-2019-00253 | Nigeria | 2,019 | National referral | Stomach | 8310/3 | Clear cell carcinoma | Well differentiated | Present | Not documented | Negative | Positive | Negative | Equivocal | 32.6 | Negative | null | Core needle biopsy | Yes | 23 | moderate_burden |
PATH-ETH-2024-00254 | Ethiopia | 2,024 | District | Bladder | 8070/3 | Squamous cell carcinoma | Well differentiated | Absent | Absent | Negative | Positive | Positive | Negative | Not done | Positive | null | Core needle biopsy | Yes | 17 | moderate_burden |
PATH-UGA-2025-00255 | Uganda | 2,025 | District | Colorectal | 8140/3 | Adenocarcinoma | Moderately differentiated | Present | Absent | Close | Positive | Positive | Not done | Not done | Positive | null | Core needle biopsy | Yes | 6 | moderate_burden |
PATH-GHA-2020-00256 | Ghana | 2,020 | National referral | Bladder | 8510/3 | Medullary carcinoma | Moderately differentiated | Absent | Present | Negative | Positive | Positive | Negative | 47.4 | Positive | null | Core needle biopsy | Yes | 26 | moderate_burden |
PATH-KEN-2023-00257 | Kenya | 2,023 | District | Liver | 8310/3 | Clear cell carcinoma | Moderately differentiated | Absent | Not documented | Not applicable | Positive | Positive | Not done | Not done | Positive | null | Resection | Yes | 11 | moderate_burden |
PATH-TAN-2023-00258 | Tanzania | 2,023 | District | Thyroid | 8070/3 | Squamous cell carcinoma | Poorly differentiated | Absent | Absent | Negative | Not done | Negative | Negative | Not done | Negative | null | Excisional biopsy | Yes | 7 | moderate_burden |
PATH-NIG-2020-00259 | Nigeria | 2,020 | District | Cervix | 8720/3 | Melanoma | Well differentiated | Present | Present | Negative | Negative | Positive | Negative | 89.7 | Positive | null | Core needle biopsy | No - inconclusive | 8 | moderate_burden |
PATH-UGA-2019-00260 | Uganda | 2,019 | Regional | Ovary | 8140/3 | Adenocarcinoma | Poorly differentiated | Present | Not documented | Close | Positive | Negative | Positive | 63.7 | Negative | null | Excisional biopsy | Yes | 6 | moderate_burden |
PATH-TAN-2025-00261 | Tanzania | 2,025 | District | Bladder | 8140/3 | Adenocarcinoma | Undifferentiated | Absent | Not documented | Negative | Negative | Positive | Negative | Not done | Positive | null | Excisional biopsy | No - suboptimal | 7 | moderate_burden |
PATH-ETH-2023-00262 | Ethiopia | 2,023 | National referral | Colorectal | 8140/3 | Adenocarcinoma | Well differentiated | Absent | Absent | Negative | Positive | Positive | Negative | 26.8 | Negative | null | Resection | Yes | 22 | moderate_burden |
PATH-TAN-2023-00263 | Tanzania | 2,023 | Regional | Ovary | 8310/3 | Clear cell carcinoma | Poorly differentiated | Present | Not documented | Negative | Positive | Negative | Negative | 53.5 | Positive | null | Core needle biopsy | Yes | 14 | moderate_burden |
PATH-UGA-2022-00264 | Uganda | 2,022 | District | Lung | 8500/3 | Ductal carcinoma | Poorly differentiated | Absent | Present | Negative | Negative | Positive | Negative | Not done | Negative | null | Resection | Yes | 4 | moderate_burden |
PATH-SOU-2023-00265 | South Africa | 2,023 | Regional | Liver | 8140/3 | Adenocarcinoma | Poorly differentiated | Absent | Not documented | Negative | Negative | Negative | Negative | Not done | Not done | null | Fine needle aspirate | Yes | 26 | moderate_burden |
PATH-TAN-2024-00266 | Tanzania | 2,024 | District | Colorectal | 8070/3 | Squamous cell carcinoma | Undifferentiated | Absent | Not documented | Negative | Negative | Not done | Negative | Not done | Not done | null | Resection | Yes | 20 | moderate_burden |
PATH-NIG-2018-00267 | Nigeria | 2,018 | District | Lung | 8430/3 | Mucoepidermoid carcinoma | Moderately differentiated | Absent | Absent | Negative | Positive | Negative | Equivocal | Not done | Negative | null | Core needle biopsy | No - suboptimal | 20 | moderate_burden |
PATH-NIG-2023-00268 | Nigeria | 2,023 | District | Breast | 8070/3 | Squamous cell carcinoma | Poorly differentiated | Present | Not documented | Negative | Negative | Negative | Negative | 28.9 | Negative | Luminal A | Core needle biopsy | Yes | 15 | moderate_burden |
PATH-UGA-2018-00269 | Uganda | 2,018 | Regional | Colorectal | 8070/3 | Squamous cell carcinoma | Poorly differentiated | Present | Absent | Negative | Negative | Negative | Negative | Not done | Positive | null | Excisional biopsy | Yes | 19 | moderate_burden |
PATH-UGA-2018-00270 | Uganda | 2,018 | Regional | Colorectal | 8310/3 | Clear cell carcinoma | Poorly differentiated | Absent | Not documented | Close | Positive | Negative | Negative | Not done | Positive | null | Excisional biopsy | Yes | 15 | moderate_burden |
PATH-ETH-2024-00271 | Ethiopia | 2,024 | District | Thyroid | 8260/3 | Papillary carcinoma | Poorly differentiated | Absent | Present | Not applicable | Positive | Negative | Negative | 42.0 | Positive | null | Core needle biopsy | Yes | 16 | moderate_burden |
PATH-KEN-2021-00272 | Kenya | 2,021 | National referral | Breast | 8070/3 | Squamous cell carcinoma | Moderately differentiated | Present | Absent | Negative | Negative | Positive | Negative | 85.1 | Positive | Triple negative | Excisional biopsy | Yes | 5 | moderate_burden |
PATH-KEN-2023-00273 | Kenya | 2,023 | District | Ovary | 8140/3 | Adenocarcinoma | Well differentiated | Absent | Present | Negative | Positive | Negative | Negative | 87.4 | Positive | null | Core needle biopsy | Yes | 17 | moderate_burden |
PATH-GHA-2021-00274 | Ghana | 2,021 | Regional | Stomach | 8260/3 | Papillary carcinoma | Moderately differentiated | Not documented | Not documented | Close | Not done | Positive | Negative | 6.4 | Positive | null | Core needle biopsy | Yes | 18 | moderate_burden |
PATH-NIG-2023-00275 | Nigeria | 2,023 | Regional | Cervix | 8260/3 | Papillary carcinoma | Well differentiated | Absent | Absent | Negative | Negative | Negative | Not done | 5.8 | Not done | null | Fine needle aspirate | No - inconclusive | 14 | moderate_burden |
PATH-SOU-2025-00276 | South Africa | 2,025 | Regional | Colorectal | 8140/3 | Adenocarcinoma | Poorly differentiated | Absent | Not documented | Negative | Positive | Not done | Negative | 19.5 | Negative | null | Resection | No - suboptimal | 24 | moderate_burden |
PATH-TAN-2023-00277 | Tanzania | 2,023 | District | Breast | 8070/3 | Squamous cell carcinoma | Poorly differentiated | Present | Present | Negative | Positive | Positive | Negative | Not done | Positive | Luminal B | Fine needle aspirate | Yes | 21 | moderate_burden |
PATH-GHA-2023-00278 | Ghana | 2,023 | District | Thyroid | 8430/3 | Mucoepidermoid carcinoma | Moderately differentiated | Absent | Absent | Negative | Not done | Negative | Positive | 6.1 | Negative | null | Core needle biopsy | Yes | 5 | moderate_burden |
PATH-SOU-2022-00279 | South Africa | 2,022 | National referral | Liver | 8510/3 | Medullary carcinoma | Moderately differentiated | Not documented | Present | Negative | Not done | Negative | Positive | 33.5 | Negative | null | Resection | Yes | 3 | moderate_burden |
PATH-ETH-2023-00280 | Ethiopia | 2,023 | District | Lung | 8140/3 | Adenocarcinoma | Undifferentiated | Present | Absent | Negative | Not done | Positive | Equivocal | Not done | Not done | null | Core needle biopsy | Yes | 12 | moderate_burden |
PATH-NIG-2021-00281 | Nigeria | 2,021 | National referral | Cervix | 8070/3 | Squamous cell carcinoma | Moderately differentiated | Absent | Absent | Negative | Negative | Negative | Negative | 25.1 | Positive | null | Excisional biopsy | No - inconclusive | 5 | moderate_burden |
PATH-GHA-2020-00282 | Ghana | 2,020 | District | Bladder | 8140/3 | Adenocarcinoma | Poorly differentiated | Absent | Absent | Close | Negative | Negative | Negative | 47.2 | Positive | null | Excisional biopsy | Yes | 13 | moderate_burden |
PATH-SOU-2021-00283 | South Africa | 2,021 | Regional | Prostate | 8070/3 | Squamous cell carcinoma | Poorly differentiated | Absent | Present | Negative | Positive | Positive | Negative | 23.9 | Not done | null | Resection | Yes | 16 | moderate_burden |
PATH-ETH-2025-00284 | Ethiopia | 2,025 | District | Stomach | 8070/3 | Squamous cell carcinoma | Poorly differentiated | Absent | Present | Positive | Positive | Positive | Negative | Not done | Negative | null | Core needle biopsy | Yes | 26 | moderate_burden |
PATH-SOU-2021-00285 | South Africa | 2,021 | National referral | Thyroid | 8310/3 | Clear cell carcinoma | Moderately differentiated | Absent | Absent | Positive | Negative | Negative | Negative | 59.5 | Positive | null | Resection | Yes | 22 | moderate_burden |
PATH-NIG-2023-00286 | Nigeria | 2,023 | District | Prostate | 8500/3 | Ductal carcinoma | Undifferentiated | Present | Absent | Negative | Not done | Positive | Negative | Not done | Negative | null | Core needle biopsy | Yes | 5 | moderate_burden |
PATH-SOU-2024-00287 | South Africa | 2,024 | National referral | Prostate | 8310/3 | Clear cell carcinoma | Poorly differentiated | Not documented | Absent | Negative | Negative | Negative | Negative | 13.3 | Negative | null | Core needle biopsy | Yes | 24 | moderate_burden |
PATH-UGA-2024-00288 | Uganda | 2,024 | Regional | Breast | 8510/3 | Medullary carcinoma | Moderately differentiated | Not documented | Absent | Negative | Negative | Negative | Negative | Not done | Positive | Luminal A | Excisional biopsy | Yes | 15 | moderate_burden |
PATH-TAN-2025-00289 | Tanzania | 2,025 | Regional | Bladder | 8140/3 | Adenocarcinoma | Moderately differentiated | Absent | Present | Negative | Not done | Positive | Negative | 22.2 | Negative | null | Core needle biopsy | Yes | 7 | moderate_burden |
PATH-NIG-2023-00290 | Nigeria | 2,023 | National referral | Breast | 8070/3 | Squamous cell carcinoma | Poorly differentiated | Not documented | Absent | Close | Negative | Negative | Positive | 62.3 | Positive | Triple negative | Excisional biopsy | Yes | 18 | moderate_burden |
PATH-KEN-2020-00291 | Kenya | 2,020 | National referral | Prostate | 8070/3 | Squamous cell carcinoma | Well differentiated | Present | Absent | Negative | Positive | Negative | Negative | 47.3 | Positive | null | Core needle biopsy | Yes | 6 | moderate_burden |
PATH-ETH-2020-00292 | Ethiopia | 2,020 | Regional | Stomach | 8500/3 | Ductal carcinoma | Poorly differentiated | Not documented | Absent | Negative | Positive | Negative | Negative | 57.7 | Negative | null | Core needle biopsy | Yes | 7 | moderate_burden |
PATH-GHA-2021-00293 | Ghana | 2,021 | Regional | Colorectal | 8140/3 | Adenocarcinoma | Poorly differentiated | Absent | Absent | Negative | Positive | Positive | Positive | Not done | Not done | null | Fine needle aspirate | Yes | 7 | moderate_burden |
PATH-SOU-2022-00294 | South Africa | 2,022 | Regional | Lung | 8500/3 | Ductal carcinoma | Poorly differentiated | Not documented | Not documented | Negative | Positive | Positive | Positive | Not done | Negative | null | Resection | Yes | 3 | moderate_burden |
PATH-ETH-2021-00295 | Ethiopia | 2,021 | Regional | Bladder | 8070/3 | Squamous cell carcinoma | Undifferentiated | Absent | Absent | Negative | Positive | Positive | Equivocal | Not done | Positive | null | Resection | Yes | 12 | moderate_burden |
PATH-TAN-2018-00296 | Tanzania | 2,018 | Regional | Colorectal | 8720/3 | Melanoma | Moderately differentiated | Not documented | Absent | Negative | Positive | Positive | Negative | Not done | Not done | null | Core needle biopsy | Yes | 24 | moderate_burden |
PATH-KEN-2022-00297 | Kenya | 2,022 | National referral | Bladder | 8140/3 | Adenocarcinoma | Poorly differentiated | Absent | Not documented | Negative | Not done | Negative | Negative | 64.8 | Positive | null | Excisional biopsy | Yes | 15 | moderate_burden |
PATH-TAN-2025-00298 | Tanzania | 2,025 | National referral | Ovary | 8070/3 | Squamous cell carcinoma | Moderately differentiated | Not documented | Absent | Close | Positive | Negative | Negative | 19.6 | Negative | null | Resection | Yes | 25 | moderate_burden |
PATH-GHA-2023-00299 | Ghana | 2,023 | District | Thyroid | 8070/3 | Squamous cell carcinoma | Moderately differentiated | Absent | Absent | Negative | Negative | Negative | Negative | 34.7 | Negative | null | Core needle biopsy | Yes | 10 | moderate_burden |
PATH-SOU-2023-00300 | South Africa | 2,023 | District | Breast | 8500/3 | Ductal carcinoma | Poorly differentiated | Absent | Absent | Not applicable | Positive | Positive | Negative | 8.0 | Negative | Triple negative | Core needle biopsy | Yes | 27 | moderate_burden |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.